Incidence of infections in clinical trials of treatments for relapsed/refractory multiple myeloma: Systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

The usual but empirical initial dose in brain tumor patients is an intravenous bolus of 10 mg of dexamethasone, followed by a maintenance dose of 4 mg given by the intravenous (IV) route every 6 hours ...

For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.

Patients with recurrent glioblastoma have a poor outcome. Data from the phase III registration trial comparing tumour-treating alternating electric fields (TTFields) vs chemotherapy provided a unique ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it is launching dexamethasone, 4mg and 6 mg, following Abbreviated New ...

Please provide your email address to receive an email when new articles are posted on . Patients with multiple myeloma who had dexamethasone dose reductions achieved similar PFS and OS as those who ...

Dexamethasone can reduce cancer-related fatigue in patients with advanced disease and can improve quality of life, but few oncologists use the steroid to manage fatigue at the end of life. In a small ...

NEW YORK--(BUSINESS WIRE)--Fera is pleased to announce that, in addition to its already marketed 100-count bottle package size, it has now launched a 100-count unit dose blister package as well. The ...

Please provide your email address to receive an email when new articles are posted on . Administration of low-dose IV dexamethasone before knee arthroplasty may improve patient outcomes for pain, ...

The results of the placebo-controlled clinical trial of adjunctive dexamethasone in the treatment of tuberculous meningitis reported by Thwaites et al. (Oct. 21 issue) 1 clearly indicate improved ...

Chronic subdural hematoma is a common neurologic disorder that is especially prevalent among older people. The effect of dexamethasone on outcomes in patients with chronic subdural hematoma has not ...